Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Fuller

Showing results (301-310 of 538) with videos related to

Pageof 54
Sort By:
Frontiers in Oncology|April 20, 2023
Concurrent IDH1 and IDH2 mutations in glioblastoma: A case reportAli S Haider, Chibawanye I Ene, Paolo Palmisciano, et al.
Postgraduate Medical Journal|December 1, 1988
Nature, incidence and prognosis of neurological involvement in the acquired immunodeficiency syndrome in central LondonR J Guiloff, G N Fuller, A Roberts, et al.
BMC Cancer|August 2, 2018
Clinical significance of FBXO17 gene expression in high-grade gliomaDi Du, Jian Yuan, Wencai Ma, et al.
Frontiers in Neurology|September 14, 2018
Primary Leptomeningeal Oligodendroglioma, IDH-Mutant, 1p/19q-CodeletedLeomar Y Ballester, Erin Dunbar, Nandita Guha-Thakurta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Loss of the AP-2alpha transcription factor is associated with the grade of human gliomasAmy B Heimberger, Eric C McGary, Dima Suki, et al.
Pediatric Neurosurgery|November 14, 2017
Extending the Neuroanatomic Territory of Diffuse Midline Glioma, K27M Mutant: Pineal Region OriginAndrea R Gilbert, Wafik Zaky, Murat Gokden, et al.
Ophthalmic Plastic and Reconstructive Surgery|September 21, 2004
Orbital and optic chiasmal extension of uveal melanomaHossein Saadati, Chris Calvano, Roxana Diba, et al.
Oncology Reports|August 4, 2005
Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progressionGregory N Fuller, Cristian Mircean, Ioan Tabus, et al.
Molecular Cancer Therapeutics|March 16, 2005
Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16Gregory N Fuller, Xiaohua Su, Roger E Price, et al.
Molecular Cancer|September 15, 2005
Attenuated expression of DFFB is a hallmark of oligodendrogliomas with 1p-allelic lossJ Matthew McDonald, Valerie Dunmire, Ellen Taylor, et al.
Pageof 54

Showing results (301-310 of 538) with videos related to

Sort By:
Pageof 54
Frontiers in Oncology|April 20, 2023
Concurrent IDH1 and IDH2 mutations in glioblastoma: A case reportAli S Haider, Chibawanye I Ene, Paolo Palmisciano, et al.
Postgraduate Medical Journal|December 1, 1988
Nature, incidence and prognosis of neurological involvement in the acquired immunodeficiency syndrome in central LondonR J Guiloff, G N Fuller, A Roberts, et al.
BMC Cancer|August 2, 2018
Clinical significance of FBXO17 gene expression in high-grade gliomaDi Du, Jian Yuan, Wencai Ma, et al.
Frontiers in Neurology|September 14, 2018
Primary Leptomeningeal Oligodendroglioma, IDH-Mutant, 1p/19q-CodeletedLeomar Y Ballester, Erin Dunbar, Nandita Guha-Thakurta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Loss of the AP-2alpha transcription factor is associated with the grade of human gliomasAmy B Heimberger, Eric C McGary, Dima Suki, et al.
Pediatric Neurosurgery|November 14, 2017
Extending the Neuroanatomic Territory of Diffuse Midline Glioma, K27M Mutant: Pineal Region OriginAndrea R Gilbert, Wafik Zaky, Murat Gokden, et al.
Ophthalmic Plastic and Reconstructive Surgery|September 21, 2004
Orbital and optic chiasmal extension of uveal melanomaHossein Saadati, Chris Calvano, Roxana Diba, et al.
Oncology Reports|August 4, 2005
Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progressionGregory N Fuller, Cristian Mircean, Ioan Tabus, et al.
Molecular Cancer Therapeutics|March 16, 2005
Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16Gregory N Fuller, Xiaohua Su, Roger E Price, et al.
Molecular Cancer|September 15, 2005
Attenuated expression of DFFB is a hallmark of oligodendrogliomas with 1p-allelic lossJ Matthew McDonald, Valerie Dunmire, Ellen Taylor, et al.
Pageof 54